Matthew Rees

19PUBLICATIONS
61CO-AUTHORS
Radiation therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 22, 2026
A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

|Mar 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapy.

Joselle Cook, Supriya Gupta, Nadine Abdallah

|Nov 12, 2025
The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis.

Matthew J Rees, Jack Khouri, Ariel F Grajales-Cruz

|Oct 16, 2025
EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity.

Suheil Albert Atallah-Yunes, Thomas M Habermann, Matthew J Rees

|Sep 03, 2025
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies.

Suheil Albert Atallah-Yunes, Chijioke C Nze, Rebecca L King

|Aug 14, 2025
The Evolving Treatment Landscape for the Elderly Multiple Myeloma Patient: From Quad Regimens to T-Cell Engagers and CAR-T.

Matthew James Rees, Hang Quach

Pageof 4

Frequent Collaborators

5 joint publications

Shaji Kumar

4 joint publications

Suheil Albert Atallah-Yunes

4 joint publications

Thomas M Habermann

4 joint publications

Yucai Wang